Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pérez-Peñate, G.
Right arrow Articles by Cabrera-Navarro, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pérez-Peñate, G.
Right arrow Articles by Cabrera-Navarro, P.
(Chest. 2001;119:970-973.)
© 2001 American College of Chest Physicians

One-Year Continuous Inhaled Nitric Oxide for Primary Pulmonary Hypertension*

Gregorio Pérez-Peñate, MD; Gabriel Julià-Serdà, MD; Juan María Pulido-Duque, MD; Elias Górriz-Gómez, MD and Pedro Cabrera-Navarro, MD

* From the Services of Pneumology (Drs. Pérez-Peñate, Julià-Serdà, and Cabrera-Navarro) and Vascular Radiology (Drs. Pulido-Duque and Górriz-Gómez), Hospital General de Gran Canaria "Dr. Negrín," Las Palmas de Gran Canaria, Spain.

Correspondence to: Gregorio Pérez-Peñate, MD, Servicio de Neumología, Hospital General de Gran Canaria "Dr. Negrín," Barranco de la Ballena s/n, E-35020 Las Palmas de Gran Canaria, Spain; e-mail: gperez{at}correo.hpino.rcanaria.es

We describe a case of long-term administration of nitric oxide (NO) in a 32-year-old man who was admitted with exertional dyspnea and anasarca. A diagnosis of primary pulmonary hypertension was made. An acute vasodilator trial with inhaled NO showed a 5% reduction of the mean pulmonary artery pressure. Long-term NO inhalation therapy was initiated. Twenty days later, the dyspnea improved, the anasarca resolved, and the PaO2 level increased. After 12 months of NO therapy, the patient remained stable and no signs of toxicity or tachyphylaxis were observed. To our knowledge, this is the first report of 1 year of continuously inhaled NO in an adult patient with primary pulmonary hypertension. These findings suggest that prolonged NO therapy might be an effective alternative, at a lower cost, to the continuous IV infusion of epoprostenol.

Key Words: nitric oxide • primary pulmonary hypertension • pulmonary vasodilator




This article has been cited by other articles:


Home page
 Arch SurgHome page
Image of the Month--Diagnosis
Arch Surg, September 1, 2004; 139(9): 1018 - 1018.
[Full Text] [PDF]

Home page
 CirculationHome page
F. Ichinose, J. D. Roberts Jr, and W. M. Zapol
Inhaled Nitric Oxide: A Selective Pulmonary Vasodilator: Current Uses and Therapeutic Potential
Circulation, June 29, 2004; 109(25): 3106 - 3111.
[Full Text] [PDF]

Home page
 BloodHome page
O. Castro, M. Hoque, and B. D. Brown
Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival
Blood, February 15, 2003; 101(4): 1257 - 1261.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American College of Chest Physicians.